Quick Results
Press Releases

Baker Donelson to Host Inaugural Louisiana Life Sciences and Technology Symposium

Share

Baker Donelson will host the inaugural Louisiana Life Sciences and Technology Symposium. The day-long event, which will be held on September 19th at Baker Donelson's New Orleans office, will bring together thought leaders and stakeholders in Louisiana's life sciences and technology ecosystem for the benefit of those companies.

Baker Donelson is committed to the success of emerging and established life sciences and technology companies in Louisiana," said Noah Kressler, co-chair of Baker Donelson's Louisiana Life Sciences and Technology Team and a member of the Firm's New Orleans office. "The purpose of this symposium is to provide expertise and exchange information so these companies can continue to grow and develop here in Louisiana, bringing investment and living wage jobs into our community."

We are excited to provide attendees with the opportunity to network with supporters of our life science and technology community," added Paula Estrada de Martin, Ph.D., co-chair of the Baker Donelson Louisiana Life Sciences and Technology Team and a member of the New Orleans office. "These connections are key to the continued growth and development of Louisiana's strategic position as a thriving player in technology and the life sciences."

The event will feature numerous representatives from industry, universities and the U.S. Patent and Trademark Office. In addition to representatives from Baker Donelson, confirmed speakers include Jacob Oyloe, Corporate Counsel at MedImmune, LLC; Pamela Hornby, Ph.D., Senior Director and Research Fellow at Janssen Pharmaceuticals; Megan Hoyt, Regional Outreach Officer with the U.S. Patent and Trademark Office; Michael Hecht, President & CEO, Greater New Orleans, Inc.; Kris Khalil, Managing Director, New Orleans BioFund; Hallie G. Dietsch, Chief People Officer, Ready Responders; and Robin Keller, Chief Operating Officer, Lubricity Labs.

Topics to be discussed will include:

  • Corporate strategy and investment;
  • Onboarding employees and employee issues facing emerging companies;
  • Creating long-lasting and successful industry and university partnerships;
  • Taking advantage of local and state economic development incentives;
  • Developing and protecting your intellectual property portfolio (including a Q&A with the USPTO); and
  • Reflections and best practices from chief operating officers.

Availability is limited and attendance is by registration only. Additional details and registration for the Louisiana Life Sciences and Technology Symposium are available here.

About Baker Donelson's Louisiana Life Sciences and Technology Practice

Baker Donelson's Louisiana Life Sciences and Technology Team has a sophisticated and unique understanding of the intellectual property, corporate, finance and other legal issues surrounding emerging and established companies in the life sciences and technology industries in Louisiana. Baker Donelson's multidisciplinary team of attorneys, patent agents and public policy experts counsel clients in all areas, including patent prosecution; business transactions, corporate finance and capital raising; tax-efficient entity selection and structuring; tax credits and economic development incentives; university technology transfer; employment law; commercial intellectual property transactions and licensing; patent portfolio growth and management; trademarks and branding; international trade; public/private partnerships; intellectual property enforcement; litigation; federal, state and local public policy, and lobbying; regulatory compliance; and information privacy and security management. Baker Donelson is the leading law firm in Louisiana dedicated to supporting and developing companies in our life sciences and technology ecosystem.

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept